You Won't Want to Miss This 1 Thing in Moderna's Earnings Report
Moderna (NASDAQ: MRNA) has been reporting quarterly billion-dollar revenue and profit since it started selling its coronavirus vaccine. CEO Stéphane Bancel even predicted the need for the vaccine this year could surpass that of last year. And Moderna already is forecasting $21 billion in vaccine sales according to advance purchase agreements so far. That's higher than last year's $18.5 billion in revenue.
So it won't be much of a surprise if the biotech delivers another billion-dollar quarter when it reports earnings this Wednesday. But there's likely to be a lot more of interest in the report than just the latest vaccine sales. In fact, there's one particular thing you'll want to look for this time around. It could give us important clues about future revenue. Let's check it out.
Image source: Getty Images.
Source Fool.com
